Publications
Publications
Publications
Scientific Transparency in
AI Drug Discovery
Explore the foundational science behind our platform and pipeline.
Publications
Mar 20, 2025
Preprint
AmesNet: A Deep Learning Model Enhancing Generalization in Ames Mutagenicity Prediction
Mar 20, 2025
Preprint
AmesNet: A Deep Learning Model Enhancing Generalization in Ames Mutagenicity Prediction
Mar 20, 2025
Preprint
AmesNet: A Deep Learning Model Enhancing Generalization in Ames Mutagenicity Prediction
Jan 26, 2025
Preprint
Demonstrating End-to-End Drug Discovery: GALILEO™ Unlocks Generative AI for Chemistry
Jan 26, 2025
Preprint
Demonstrating End-to-End Drug Discovery: GALILEO™ Unlocks Generative AI for Chemistry
Jan 26, 2025
Preprint
Demonstrating End-to-End Drug Discovery: GALILEO™ Unlocks Generative AI for Chemistry
Jan 14, 2025
Preprint
MDL-001: An Oral, Safe, and Well-Tolerated Broad-Spectrum Inhibitor of Viral Polymerases
Jan 14, 2025
Preprint
MDL-001: An Oral, Safe, and Well-Tolerated Broad-Spectrum Inhibitor of Viral Polymerases
Jan 14, 2025
Preprint
MDL-001: An Oral, Safe, and Well-Tolerated Broad-Spectrum Inhibitor of Viral Polymerases
Apr 8, 2024
Preprint
Model Medicines Reveals Breakthrough AI Discovery: RdRp Thumb-1, A Universal RNA Antiviral Target, and MDL-001, a Potent Inhibitor
Apr 8, 2024
Preprint
Model Medicines Reveals Breakthrough AI Discovery: RdRp Thumb-1, A Universal RNA Antiviral Target, and MDL-001, a Potent Inhibitor
Apr 8, 2024
Preprint
Model Medicines Reveals Breakthrough AI Discovery: RdRp Thumb-1, A Universal RNA Antiviral Target, and MDL-001, a Potent Inhibitor
White Papers
Mar 11, 2024
Paper
Dissimilar, Drug-Like, Novel Chemical Entities (DDL-NCEs); Using Multimodal Generative AI
Mar 11, 2024
Paper
Dissimilar, Drug-Like, Novel Chemical Entities (DDL-NCEs); Using Multimodal Generative AI
Mar 11, 2024
Paper
